DYN
Price
$14.70
Change
+$0.71 (+5.08%)
Updated
Jun 6 closing price
Capitalization
1.59B
53 days until earnings call
PCVX
Price
$36.99
Change
+$2.19 (+6.29%)
Updated
Jun 6 closing price
Capitalization
4.49B
65 days until earnings call
Interact to see
Advertisement

DYN vs PCVX

Header iconDYN vs PCVX Comparison
Open Charts DYN vs PCVXBanner chart's image
Dyne Therapeutics
Price$14.70
Change+$0.71 (+5.08%)
Volume$2.67M
Capitalization1.59B
Vaxcyte
Price$36.99
Change+$2.19 (+6.29%)
Volume$1.58M
Capitalization4.49B
DYN vs PCVX Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. PCVX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and PCVX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (DYN: $11.76 vs. PCVX: $31.38)
Brand notoriety: DYN and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 33% vs. PCVX: 81%
Market capitalization -- DYN: $1.59B vs. PCVX: $4.49B
DYN [@Biotechnology] is valued at $1.59B. PCVX’s [@Biotechnology] market capitalization is $4.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • PCVX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а 0.00% price change this week, while PCVX (@Biotechnology) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

PCVX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.49B) has a higher market cap than DYN($1.59B). DYN YTD gains are higher at: -50.085 vs. PCVX (-61.666). DYN has higher annual earnings (EBITDA): -342.21M vs. PCVX (-448.08M). PCVX has more cash in the bank: 1.75B vs. DYN (642M). DYN has less debt than PCVX: DYN (24M) vs PCVX (71.1M). DYN (0) and PCVX (0) have equivalent revenues.
DYNPCVXDYN / PCVX
Capitalization1.59B4.49B35%
EBITDA-342.21M-448.08M76%
Gain YTD-50.085-61.66681%
P/E RatioN/AN/A-
Revenue00-
Total Cash642M1.75B37%
Total Debt24M71.1M34%
TECHNICAL ANALYSIS
Technical Analysis
DYNPCVX
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 12 days ago
80%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
75%
MACD
ODDS (%)
Bearish Trend 12 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 26 days ago
89%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 13 days ago
71%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+0.51%
CRNX - DYN
53%
Loosely correlated
+1.39%
RNA - DYN
51%
Loosely correlated
+1.81%
ERAS - DYN
51%
Loosely correlated
+1.85%
KYMR - DYN
50%
Loosely correlated
+2.35%
XNCR - DYN
50%
Loosely correlated
-2.58%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with RCKT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-1.10%
RCKT - PCVX
44%
Loosely correlated
+6.44%
ORKA - PCVX
43%
Loosely correlated
+0.26%
DNLI - PCVX
43%
Loosely correlated
-1.29%
DYN - PCVX
40%
Loosely correlated
+0.51%
VCEL - PCVX
39%
Loosely correlated
+0.07%
More